Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
Gordon Carl L bought 950,000 Adarx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 30, 2026
On Sep 28, 2026, Gordon Carl L (Director, 10% owner) bought 950,000 Adarx Pharmaceuticals, Inc. shares at US$17.00 for US$16.1M, leaving 588,235 shares. Filed Sep 30, 2026 (Form 4).
- Bought
- 950,000 shares
- Price
- US$17.00
- Value
- US$16.1M
- Holding after
- 588,235 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Conversion | 10,690,530 | 10,690,530 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 2,000,962 | 12,691,492 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 769,601 | 13,461,093 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 564,187 | 14,025,280 | Indirect | |
| Sep 28, 2026 | Common Stock | Buy | 300,249 | US$17.00 | 14,325,529 | Indirect |
| Sep 28, 2026 | Common Stock | Conversion | 7,127,019 | 7,127,019 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 1,333,975 | 8,460,994 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 513,067 | 8,974,061 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 256,448 | 9,230,509 | Indirect | |
| Sep 28, 2026 | Common Stock | Buy | 61,516 | US$17.00 | 9,292,025 | Indirect |
| Sep 28, 2026 | Common Stock | Buy | 588,235 | US$17.00 | 588,235 | Indirect |
Source
Related
- Adarx Pharmaceuticals, Inc.
- Gordon Carl L
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026